Role of Preoperative Antibiotic Treatment While Awaiting Appendectomy: The PERFECT-Antibiotics Randomized Clinical Trial.

IF 15.7 1区 医学 Q1 SURGERY
Karoliina Jalava,Ville Sallinen,Hanna Lampela,Hanna Malmi,Ingeborg Steinholt,Knut Magne Augestad,Ari Leppäniemi,Panu Mentula
{"title":"Role of Preoperative Antibiotic Treatment While Awaiting Appendectomy: The PERFECT-Antibiotics Randomized Clinical Trial.","authors":"Karoliina Jalava,Ville Sallinen,Hanna Lampela,Hanna Malmi,Ingeborg Steinholt,Knut Magne Augestad,Ari Leppäniemi,Panu Mentula","doi":"10.1001/jamasurg.2025.1212","DOIUrl":null,"url":null,"abstract":"Importance\r\nAntibiotics are thought to decelerate inflammation progression and reduce complications in acute uncomplicated appendicitis. The evidence of their effectiveness is insufficient, and treatment practices vary widely.\r\n\r\nObjective\r\nTo investigate the effect of preoperatively started antibiotic treatment on the rate of appendiceal perforation.\r\n\r\nDesign, Setting, and Participants\r\nThis multicenter, noninferiority, open-label randomized clinical trial was conducted in 2 hospitals in Finland and 1 hospital in Norway between May 18, 2020, and January 22, 2023. Data analysis was performed from March 2023 to March 2024. Eligible patients were adults (aged >18 years) diagnosed with presumed uncomplicated acute appendicitis. Patients with allergies or other contraindications to study antibiotics, previously started antibiotic treatment, pregnancy, a suspicion of perforated appendicitis, or other reasons to perform prompt surgery were excluded. Patients were randomized 1:1 with a web-based service simultaneously as the laparoscopic appendectomy was scheduled.\r\n\r\nInterventions\r\nAntibiotic treatment started while waiting for surgery (cefuroxime, 1500 mg, and metronidazole, 500 mg, every 8 hours until the surgery) or waiting without antibiotic treatment. Patients in both groups received a single prophylactic dose of antibiotics in the induction of anesthesia.\r\n\r\nMain Outcomes and Measures\r\nThe primary outcome was perforated appendicitis diagnosed during surgery. The absolute difference in perforation rates was compared between the groups by an intention-to-treat analysis, and the predefined noninferiority margin was 5 percentage points. Secondary outcomes included surgical site infections within 30 days.\r\n\r\nResults\r\nA total of 1797 patients were randomly assigned to either the antibiotic group (n = 901) or no-antibiotic group (n = 896). Median (IQR) patient age was 35 (28-46) years, and 793 patients (45%) were female. After randomization, 23 patients (1.3%) were excluded, leaving 1774 patients for the intention-to-treat analyses. The difference between the appendiceal perforation rates met the noninferiority threshold: 74 of 888 patients in the antibiotic group (8.3%) vs 79 of 886 patients in the no-antibiotic group (8.9%; absolute difference, 0.6 percentage points; 95% CI, -2.0 to 3.2 percentage points; P = .66; risk ratio, 1.07; 95% CI, 0.79 to 1.45). For secondary outcome, the surgical site infection rate was slightly lower in the antibiotic group (14 of 887 [1.6%]) vs the no-antibiotic group (28 of 886 [3.2%]; absolute difference, 1.6 percentage points; 95% CI, 0.2 to 3.0 percentage points; P = .03).\r\n\r\nConclusions and Relevance\r\nIn this multicenter noninferiority randomized clinical trial, preoperatively started antibiotic treatment did not decrease the risk of appendiceal perforation when appendectomy was performed within 24 hours in adult patients with presumed uncomplicated acute appendicitis.\r\n\r\nTrial Registration\r\nEudraCT Identifier: 2019-002348-26.","PeriodicalId":14690,"journal":{"name":"JAMA surgery","volume":"10 1","pages":""},"PeriodicalIF":15.7000,"publicationDate":"2025-05-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JAMA surgery","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1001/jamasurg.2025.1212","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 0

Abstract

Importance Antibiotics are thought to decelerate inflammation progression and reduce complications in acute uncomplicated appendicitis. The evidence of their effectiveness is insufficient, and treatment practices vary widely. Objective To investigate the effect of preoperatively started antibiotic treatment on the rate of appendiceal perforation. Design, Setting, and Participants This multicenter, noninferiority, open-label randomized clinical trial was conducted in 2 hospitals in Finland and 1 hospital in Norway between May 18, 2020, and January 22, 2023. Data analysis was performed from March 2023 to March 2024. Eligible patients were adults (aged >18 years) diagnosed with presumed uncomplicated acute appendicitis. Patients with allergies or other contraindications to study antibiotics, previously started antibiotic treatment, pregnancy, a suspicion of perforated appendicitis, or other reasons to perform prompt surgery were excluded. Patients were randomized 1:1 with a web-based service simultaneously as the laparoscopic appendectomy was scheduled. Interventions Antibiotic treatment started while waiting for surgery (cefuroxime, 1500 mg, and metronidazole, 500 mg, every 8 hours until the surgery) or waiting without antibiotic treatment. Patients in both groups received a single prophylactic dose of antibiotics in the induction of anesthesia. Main Outcomes and Measures The primary outcome was perforated appendicitis diagnosed during surgery. The absolute difference in perforation rates was compared between the groups by an intention-to-treat analysis, and the predefined noninferiority margin was 5 percentage points. Secondary outcomes included surgical site infections within 30 days. Results A total of 1797 patients were randomly assigned to either the antibiotic group (n = 901) or no-antibiotic group (n = 896). Median (IQR) patient age was 35 (28-46) years, and 793 patients (45%) were female. After randomization, 23 patients (1.3%) were excluded, leaving 1774 patients for the intention-to-treat analyses. The difference between the appendiceal perforation rates met the noninferiority threshold: 74 of 888 patients in the antibiotic group (8.3%) vs 79 of 886 patients in the no-antibiotic group (8.9%; absolute difference, 0.6 percentage points; 95% CI, -2.0 to 3.2 percentage points; P = .66; risk ratio, 1.07; 95% CI, 0.79 to 1.45). For secondary outcome, the surgical site infection rate was slightly lower in the antibiotic group (14 of 887 [1.6%]) vs the no-antibiotic group (28 of 886 [3.2%]; absolute difference, 1.6 percentage points; 95% CI, 0.2 to 3.0 percentage points; P = .03). Conclusions and Relevance In this multicenter noninferiority randomized clinical trial, preoperatively started antibiotic treatment did not decrease the risk of appendiceal perforation when appendectomy was performed within 24 hours in adult patients with presumed uncomplicated acute appendicitis. Trial Registration EudraCT Identifier: 2019-002348-26.
等待阑尾切除术时术前抗生素治疗的作用:perfect -抗生素随机临床试验。
重要性抗生素被认为可以减缓炎症进展,减少急性无并发症阑尾炎的并发症。证明其有效性的证据不足,治疗方法差异很大。目的探讨术前开始抗生素治疗对阑尾穿孔发生率的影响。设计、环境和参与者这项多中心、非劣效性、开放标签随机临床试验于2020年5月18日至2023年1月22日在芬兰的2家医院和挪威的1家医院进行。数据分析时间为2023年3月至2024年3月。符合条件的患者为推定为无并发症急性阑尾炎的成人(年龄在bb0 ~ 18岁)。排除对抗生素过敏或有其他禁忌症、曾接受过抗生素治疗、怀孕、怀疑阑尾炎穿孔或其他原因需要立即手术的患者。在安排腹腔镜阑尾切除术的同时,患者以1:1的比例随机选择基于网络的服务。干预措施:在等待手术时开始抗生素治疗(头孢呋辛1500毫克,甲硝唑500毫克,每8小时一次,直到手术)或等待没有抗生素治疗。两组患者在麻醉诱导时均给予单剂量预防性抗生素。主要结局和措施主要结局是手术中诊断的阑尾炎穿孔。通过意向治疗分析比较两组间穿孔率的绝对差异,预定义的非劣效性裕度为5个百分点。次要结果包括30天内手术部位感染。结果1797例患者随机分为抗生素组(n = 901)和非抗生素组(n = 896)。中位(IQR)患者年龄为35岁(28-46岁),女性793例(45%)。随机化后,23例患者(1.3%)被排除,剩下1774例患者进行意向治疗分析。阑尾穿孔率的差异符合非效性阈值:抗生素组888例患者中有74例(8.3%)vs非抗生素组886例患者中有79例(8.9%);绝对差0.6个百分点;95% CI, -2.0 ~ 3.2个百分点;p = .66;风险比1.07;95% CI, 0.79 ~ 1.45)。对于次要结局,抗生素组的手术部位感染率(887例中14例[1.6%])略低于无抗生素组(886例中28例[3.2%]);绝对差1.6个百分点;95% CI, 0.2 ~ 3.0个百分点;p = .03)。结论和相关性在这项多中心非效性随机临床试验中,假定为无并发症急性阑尾炎的成年患者在24小时内行阑尾切除术时,术前开始抗生素治疗并没有降低阑尾穿孔的风险。试验注册编号:2019-002348-26。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
JAMA surgery
JAMA surgery SURGERY-
CiteScore
20.80
自引率
3.60%
发文量
400
期刊介绍: JAMA Surgery, an international peer-reviewed journal established in 1920, is the official publication of the Association of VA Surgeons, the Pacific Coast Surgical Association, and the Surgical Outcomes Club.It is a proud member of the JAMA Network, a consortium of peer-reviewed general medical and specialty publications.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信